iA Global Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.96M Buy
+18,009
New +$6.68M 0.08% 176
2025
Q2
Sell
-18,192
Closed -$7.91M 434
2025
Q1
$7.91M Sell
18,192
-46,793
-72% -$18.8M 0.14% 124
2024
Q4
$24M Sell
64,985
-8,646
-12% -$3.62M 0.42% 47
2024
Q3
$38.3M Buy
73,631
+2,729
+4% +$1.46M 0.67% 32
2024
Q2
$38.4M Sell
70,902
-9,254
-12% -$4.89M 0.73% 21
2024
Q1
$41.6M Buy
80,156
+318
+0.4% +$158K 0.85% 20
2023
Q4
$37.6M Buy
79,838
+24,754
+45% +$11.4M 0.87% 22
2023
Q3
$24M Buy
55,084
+5,058
+10% +$2.29M 0.63% 34
2023
Q2
$22.2M Buy
+50,026
New +$23.1M 0.59% 37

Other funds holding ELV

iA Global Asset Management's ELV Position: Q2 2026 in Review

iA Global Asset Management opened a new position in Elevance Health (ELV) in Q2 2026: 18,009 shares worth $6.96M. The stake represents 0.08% of the portfolio and ranks #176 among its holdings. This is a return to the name: iA Global Asset Management previously reported a position in ELV as recently as Q1 2025.

iA Global Asset Management first reported a position in ELV in Q2 2023 and has held it in 9 quarters since. The position peaked at $41.6M in Q1 2024. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • iA Global Asset Management held 18,009 shares of Elevance Health worth $6.96M as of Q2 2026.
  • Elevance Health was a new iA Global Asset Management position in Q2 2026.
  • Elevance Health made up 0.08% of iA Global Asset Management's portfolio in Q2 2026, its #176 holding.
  • iA Global Asset Management first reported a position in Elevance Health in Q2 2023 and has held it in 9 quarters since.
  • iA Global Asset Management's Elevance Health position peaked at $41.6M in Q1 2024.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.